Literature DB >> 6091597

Radionuclide thyroid angiography and surgical correlation. A five-year study.

R D Moe, S F Frankel, A K Chacko, D W Yim, M W Clark.   

Abstract

Only 15% to 25% of cold nodules on conventional static thyroid scans are malignant. Radionuclide angiography of the thyroid and conventional static scans using sodium pertechnetate Tc 99m were performed on 114 patients who underwent thyroid surgery within a five-year period. The combined use of radionuclide angiography and conventional static scans increased the specificity for the diagnosis of thyroid carcinoma from 42% to 79% over static scans alone. The incidence of carcinoma in solitary cold nodules in our population was increased from 26% on static scans to 60% if the lesion was hypervascular on radionuclide angiography. Eighty-seven percent of hypervascular solitary cold nodules were neoplasms (carcinomas and adenomas). Hypervascularity as demonstrated by radionuclide angiography is predictive of thyroid neoplasia. The finding of a hypervascular, solitary cold nodule makes a recommendation for surgery predictive and reasonable.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6091597     DOI: 10.1001/archotol.1984.00800370019004

Source DB:  PubMed          Journal:  Arch Otolaryngol        ISSN: 0003-9977


  2 in total

1.  A comparison of radionuclide thyroid angiography, (99m)Tc-MIBI scintigraphy and power Doppler ultrasonography in the differential diagnosis of solitary cold thyroid nodules.

Authors:  Koray Demirel; Ozlem Kapucu; Cem Yücel; Hakan Ozdemir; Göksun Ayvaz; Ferit Taneri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-03-01       Impact factor: 9.236

2.  Comparison of thyroid blood flow and uptake indices using technetium-99m pertechnetate in patients with graves' disease and euthyroid subjects.

Authors:  Hamid Javadi; Ali Mahmoud Pashazadeh; Mehdi Mogharrabi; Iraj Nabipour; Mohammadreza Kalantarhormozi; Majid Assadi
Journal:  Mol Imaging Radionucl Ther       Date:  2014-10-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.